Clinical Trials Sponsored by Io Therapeutics
Total 6343 results
-
Allyx TherapeuticsMichael J. Fox Foundation for Parkinson's ResearchActive, not recruitingDementia | Alzheimer DiseaseUnited States
-
Craig L Slingluff, JrCelldex TherapeuticsActive, not recruitingMelanoma | Ocular Melanoma | Uveal MelanomaUnited States
-
Merit E. Cudkowicz, MDPrilenia TherapeuticsCompleted
-
Oui Therapeutics, Inc.National Institute of Mental Health (NIMH)Enrolling by invitationSuicidal Ideation | Suicide, AttemptedUnited States
-
SiteOne Therapeutics, Inc.National Institute on Drug Abuse (NIDA)TerminatedAcute, Post-operative PainUnited States
-
Lowell Anthony, MDTerSera Therapeutics LLCTerminated
-
InterveXion Therapeutics, LLCNational Institute on Drug Abuse (NIDA)Completed
-
Cellphire Therapeutics, Inc.Department of Health and Human ServicesCompletedHematologic Diseases | Thrombocytopenia | Bone Marrow AplasiaUnited States, Norway
-
Olatec Therapeutics LLCCTI Clinical Trial and Consulting ServicesTerminatedCovid19 | Cytokine Release SyndromeUnited States, Switzerland
-
Nektar TherapeuticsMerck Sharp & Dohme LLC; SFJ Pharmaceuticals, Inc.TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States, Austria, Greece, Italy
-
Affect Therapeutics, Inc.National Institute on Drug Abuse (NIDA)CompletedMethamphetamine AbuseUnited States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsGOG FoundationCompletedRecurrent Platinum Resistant Ovarian CancerUnited States, Israel, Japan, Poland, Spain
-
Mads Peter Godtfeldt StemmerikEdgewise Therapeutics, Inc.CompletedBecker Muscular Dystrophy | McArdle Disease | Limb-Girdle Muscular Dystrophy Type 2Denmark
-
University of North Carolina, Chapel HillFlexion Therapeutics, Inc.Completed
-
Northwestern UniversityNational Cancer Institute (NCI); Vasgene Therapeutics, IncActive, not recruitingProgressive Disease | Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Adenocarcinoma | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone | Castration-Resistant Prostate Carcinoma Refractory to Second-Generation... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Marker Therapeutics, Inc.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Nektar TherapeuticsCompleted
-
Kymera Therapeutics, Inc.York Dermatology Clinic and Research CentreCompletedDermatitis, Atopic | Hidradenitis SuppurativaCanada
-
Horizon Therapeutics, LLCTerminatedUrea Cycle DisorderUnited States
-
Scioderm, Inc.Food and Drug Administration (FDA); Amicus TherapeuticsTerminatedEpidermolysis BullosaUnited States
-
Regend TherapeuticsThe First Affiliated Hospital of Soochow UniversityUnknownChronic Respiratory DiseaseChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityEureka Therapeutics Inc.UnknownLiver Neoplasms | Hepatocellular Carcinoma | Liver Cancer | Metastatic Liver CancerChina
-
Horizon Therapeutics, LLCCompletedUrea Cycle DisorderUnited States, Canada
-
Insight Therapeutics, LLCBrown University; Case Western Reserve UniversityUnknown
-
Instituto Bioclon S.A. de C.V.Rare Disease Therapeutics Inc.CompletedLatrodectismUnited States
-
Melinta Therapeutics, Inc.Department of Health and Human ServicesCompletedBacterial InfectionUnited States, Bulgaria
-
Bioheart, Inc.Anupam Hospital; RegennMed Research and Therapeutics DelhiCompleted
-
CF Therapeutics Development Network Coordinating...Cystic Fibrosis FoundationCompletedCystic FibrosisCanada, United States
-
vTv TherapeuticsNational Heart, Lung, and Blood Institute (NHLBI)Terminated
-
Ocular Therapeutix, Inc.Duke University; FortreaRecruitingNeovascular Age-Related Macular DegenerationUnited States
-
Midwest Eye InstituteOcular Therapeutix, Inc.Terminated
-
Grene Vision GroupOcular Therapeutix, Inc.Completed
-
The Cleveland ClinicOcular Therapeutix, Inc.Enrolling by invitationOcular Inflammation | Post-operative Pain | Vitreoretinal Surgery | Post-Operative InflammationUnited States
-
New England Retina AssociatesOcular TherapeutixUnknown
-
Eli Lilly and CompanyAlzheimer's Therapeutic Research InstituteCompletedCognition DisordersUnited States, Canada, Australia, Japan
-
Alfa Intes Industria Terapeutica Splendore s.r.l.Not yet recruiting
-
Tufts Medical CenterOcular Therapeutix, Inc.Recruiting
-
Vance Thompson VisionOcular Therapeutix, Inc.CompletedRefractive SurgeryUnited States
-
Silverstein Eye CentersOcular Therapeutix, Inc.CompletedCataract SurgeryUnited States
-
Prism Vision GroupOcular Therapeutix, Inc.UnknownOcular Surface Disease | Dry Eye Disease | Cataract Surgery
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eli Lilly and Company; Genentech, Inc.; Kazia... and other collaboratorsRecruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Brain | NTRK Family Gene Mutation | CDK Gene Mutation | PI3K Gene Mutation | ROS1 Gene Mutation | KRAS G12C MutationUnited States
-
Johns Hopkins UniversityNational Multiple Sclerosis Society; Axsome Therapeutics, Inc.RecruitingMultiple Sclerosis | Multiple Sclerosis FatigueUnited States
-
Aardvark Therapeutics, Inc.Center for Psychiatry And Behavioral Medicine Inc.RecruitingAutism Spectrum DisorderUnited States
-
Sir Run Run Shaw HospitalHangzhou Neoantigen Therapeutics Co., Ltd.Recruiting
-
HuidaGene Therapeutics Co., Ltd.Eye & ENT Hospital of Fudan UniversityNot yet recruitingCongenital Hearing LossChina
-
Merz Therapeutics GmbHHeinrich-Heine University, DuesseldorfRecruitingCervical DystoniaGermany
-
Centessa Pharmaceuticals (UK) LimitedLockBody Therapeutics LtdRecruitingAdvanced Solid TumorUnited States, France
-
The First Affiliated Hospital of Soochow UniversityFundamenta Therapeutics, Ltd.RecruitingCAR | Refractory Acute Lymphoblastic Leukemia | Relapsed Adult ALLChina
-
The Affiliated People's Hospital of Ningbo UniversityUTC Therapeutics Inc.RecruitingLymphoma | Leukemia | Myeloma | Relapsed/Refractory Hematological MalignanciesChina
-
Fundamenta Therapeutics, Ltd.The Affiliated Hospital of Xuzhou Medical UniversityRecruitingB-cell MalignancyChina